Lecture abstract:

I will present two patient case studies of chronic inflammation induced by long COVID and post-vaccine syndrome. I will discuss, compare, and contrast the differences in the individual patients and how to approach treating these patients with a tailored approach.

Dr. Carvallo is an endocrinologist, retired professor at Argentina’s University of Buenos Aires, and former director of one of the city’s largest hospitals. He and a colleague conducted the first human trials of ivermectin for the prevention of COVID-19, and he has led investigations into the potential use of other repurposed drugs, including bromhexine, dexamethasone, aspirin, enoxaparin, and carrageenan for COVID. A highly published author, he has successfully treated thousands of COVID patients.